CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

As pharmaceutical breakthroughs offer new treatment options, people are paying more attention to the coverage their employers ...

CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.

CVS operates 25 sites in San Jose, with another one roughly two miles from the recently sold site. The 5407 Camden Ave.

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

A pharmacy location near downtown Florence, Five Points, Timrod Park, is permanently shutting down. It will move ...

We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...